Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × Exercise × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 7 Obesity 2 Neoplasms 2 Breast Neoplasms 2 Sarcopenia 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphedema 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Brain Neoplasms 1 Anomia 1 Alzheimer Disease 1

Interventions

Oxaliplatin 9 Cetuximab 8 Bevacizumab 7 pembrolizumab 5 Leucovorin 5 Fluorouracil 5 Irinotecan 4 Pemetrexed 3 Gemcitabine 3 Cisplatin 3 Carboplatin 3 Capecitabine 3 fludarabine 2 adagrasib 2 Specimen Handling 2 Paclitaxel 2 Folfox protocol 2 Cyclophosphamide 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 sintilimab 1 ropidoxuridine 1 relatlimab 1 palbociclib 1 encorafenib 1 durvalumab 1 dostarlimab 1 dehydroftorafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05579340 2026-02-24

POET-mCRC

Rigshospitalet, Denmark

Phase NA Active not recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡